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1. Introduction 
In the elongation cycle, the binding of the ternary 
complex EF-Tu . GTP . aa-tRNA to the mRNA . ribo- 
some complex is accompanied by the hydrolysis of 
GTP, a prerequisite for the release of EF-Tu from the 
ribosome (review [ 1 I). We have utilized the antibiotic 
kirromycin to analyze the role of the individual com- 
ponents of the EF-Tudependent GTPase reaction, 
since this compound allows EF-Tu to support a turn- 
over of GTPase activity which is specifically stimulated 
by aa-tRNA and ribosomes [2-61. As in the physio- 
logical system, only aminoacylated tRNA and not 
deacylated tRNA orN-acetylaminoacyl-tRNA displays 
an effect in the kirromycin-dependent activity. Kirro- 
mycin can be therefore a useful tool to study the 
involvement of the 3’-terminal end of aa-tRNA in the 
GTPase activity of EF-Tu. 
Here, we show that 3’-terminal aa-tRNA fragments, 
containing l-5 residues, can stimulate the GTPase 
activity of EF-Tu induced by kirromycin. The effect, 
which occurs already with 2’(3’)-O-L-aminoacyladen- 
osine, is increased by the presence of the other resi- 
dues, the penultimate one playing a critical role. Ribo- 
somes enhance the sensitivity of the system. 
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2. Materials and methods 
All biological components, materials and methods 
not quoted in this section were as in [2-81. Pure EF- 
Tu and NH4C1-washed ribosomes were from Esche- 
richia coli MRE 600. Kirromycin (= mocimycin, [S]) 
was obtained from Dr H. Wolf (University of Tiibingen) 
and Dr R. Beukers (Gist-Brocades, Delft). Cytosine3’- 
monophosphate was from Boehringer and puromycin 
from Sigma or Serva. The tRNAPhe (25-1000/c pure) 
and tRNA7” (25-50% pure, a gift of Dr G. Sander) 
were isolated from total tRNA (Schwarz/Mann) by 
chromatography on BD-cellulose and Sepharose 4B 
(Pharmacia) [9,10]. The various 3’-terminal fragments 
(CACCA-Phe, CCA-Phe, CA-Phe, A-Phe, CCA-Val, 
CA-Val and A-Val) were obtained from [ 14C]Phe- 
tRNAPhe (spec. act. 50 cpm/pmol) and [ 14C]Val- 
tRNA\ia’ (spec. act. 50 cpm/pmol) according to 
known methods of enzymatic digestion with RNase 
T1 (Calbiochem), RNase UZ, calf spleen phosphodi- 
esterase and pancreatic RNase (all from Boehringer) 
[ 11 ,121. They were purified by chromatography on 
DEAE-Sephadex A-25 (Pharmacia) at pH 4.5, fol- 
lowed by chromatography on SP-Sephadex C-25 
(Pharmacia) at pH 3.5. Elutions were carried out 
with a gradient of ammonium acetate. For CA-Phe 
and CA-V.al an additional electrophoretic step on 
Whatmann 3 MM paper at pH 3.5 and 50 V/cm (Gilson 
Electrophorator) was employed. Purity of the frag- 
ments, calculated spectrophotometrically and by spe- 
cificactivity,was90-lOO%.The fragmentswere>95% 
aminoacylated. After lyophilisation, the fragments 
were dissolved in 2 mM acetic acid and kept at -70°C. 
Particular care was taken to avoid the presence of 
monovalent cations in the final solution, since they 
greatly influence the EF-Tu . kirromycin GTPase 
activity [7]. 
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To increase the stimulatory effect of aa-tRNA, in 
the absence of ribosomes we have worked at 25 mM 
NH4C1 while the MgCl, concentration, which is not 
critical, was 10 mM. Stimulation by Phe-tRNA was 
-7-fold. Since in these ionic conditions ribosomes 
enhance the GTPase activity of EF-Tu . kirromycin in 
the absence of aa-tRNA considerably [7], in their 
presence we have modified the ionic concentrations 
(5 mM NH4C1 and 30 mM M&l*) to obtain a stronger 
stimulation by aa-tRNA (9-12-fold with Phe- 
tRNAPhe) thanks to the lower background of GTPase 
activity. Under all conditions tested the GTP concen- 
tration was saturating and the reaction kinetics linear. 
Most assays were carried out in 10 ~1 final vol., the 
results being comparable with those obtained in 15 and 
75 1.11. The reaction was started with [y-32P]GTP (spec. 
act. 1500-4000 cpm/pmol). The non-hydrolyzed 
[T-~‘P]GTP was sequestered by addition of activated 
charcoal in 1 M HCl [ 131 and the mixture was centri- 
fuged for 15 min at 5000 rev./min. An aliquot of the 
supernatant was added to Aquasol 2 (New England 
Nuclear) and the radioactivity of 32Pi counted in an 
Intertechnique SL 4000 liquid scintillation spectrom- 
eter. 
3. Results 
To obtain some indications of the role of the amino 
acid residuds in the interaction with EF-Tu, we have 
done our experiments with fragments derived from 
two different aa-tRNAs. 
Fig.1 illustrates the effect of increasing concentra- 
tions of Phe-tRNAPhe (panel A) and Val-tRNAyd 
(panel B) and their 3’-terminal fragments on the rate 
of the EF-Tu-dependent GTP hydrolysis induced by 
kirromycin in the absence of ribosomes. Stimulation 
of the GTPase activity by CACCA-Phe, the longest 
aminoacyloligonucleotide used, was stronger than 
with CCA-Phe and A-Phe, the latter fragment being 
by far the least active. In this system CA-Phe was not 
tested. A similar pattern was observed with the 
3’-terminal fragments derived from Val-tRNAFl:CCA- 
Val and CA-Val were both as active as CCA-Phe while 
the effect of A-Val was as little as that of A-Phe. With 
both intact aa-tRNAs, stimulation was,however,much 
stronger than with the derived fragments. 
Fig.2 illustrates the same series of experiments in 
the presence of ribosomes. Also in this system the 




1:ig.l. The rate of GTP hydrolysis catalyzed by Et:-Tu in the 
presence of kirromycin as a function of the concentration of 
Phe-tRNAPhe (A), V&RNA?’ (B) and their 3’.terminal 
fragments. The reaction mixture contained in 10 ~1 final vol.: 
50 mM imidazolium acetate (pH 7 .O); 25 mM NH,Cl; 10 mM 
M&l,; 30 pmol [y-‘2P]CTP (spec. act. 3500 cpm/pmol); 
Phe-tRNAPhe (A) or Val-tRNA?al (B) and the respective 
3’.terminal fragments as indicated; 50 PM kirromycin;4 pmol 
BF-Tu. After 15 min incubation at 30°C the reaction was 
stopped with 50 ~1 0.6 M HCIO, and the .‘ZPi liberated was 
measured as in section 2. (A) Phc-tRNAPhe (0); CACCA-Phe 
(A); CCA-Phe (A); A-Phe (a). (B) Val-tRNAp’ (0); CCA-Val 
(A); CA-Val (0); A-Val (=). 
Fig.2. The rate of (;TP hydrolysis catalyzed by EF-Tu in the 
presence of kirromycin and ribosomes as a function of the 
concentration of Phe-tRNAPhe (A), Val-tRNApl (B) and 
their 3’-terminal fragments. The reaction mixture contained 
in 10 ~1 final vol.: 30 mM imidazolium acetate (pH 7.0); 
5 mM NH&l, 30 mM MgCI,, 100 pmol [y-“P]GTP 
I 1500 cpm/pmol), Phe-tRNAPhe (A) or Val-tRNAp 
spec.act. 
(B) and 
the respective fragments as indicated; 50 MM kirromycin; 
4 pmol EF-Tu; 4 pm01 70 S ribosomes. After 15 min incuba- 
tion at 3O”C, the reaction was stopped with 50 ~10.6 M 
HClO, and the “Pi liberated was measured as in section 2. 
(A) Phe-tRNAPh” (G); CACCAPhe (‘4); CCAPhe (A); CA-Phe 
(0); A-Phe (=). (B) Val-tRNAp’ (0); CCA-Val (A); CA-Vat 
(n); A-Val (=). (A,B) EF-Tu + kirromycin and ribosomes 
without additions (--). 
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that CCA-Phe enhances the rate of GTP hydrolysis as 
well as CACCAPhe. CA-Phe was 50% as effective, 
while APhe was again the least effective. Stimulation 
by CCA-Val reached almost that obtained with 
Val-tRNAyat; CA-Val was somewhat less active than 
CCA-Val, while stimulation by A-Val was very small, 
being almost that of A-Phe. 
In both systems, saturating concentrations of 
Phe-tRNAP1re induced a 50% stronger stimulation than 
did Val-tRNAya’. The difference in the stimulation by 
the intact molecules was not conserved in the magni- 
tude of the effect for their derived fragments. 
Deacylated 3’-terminal fragments were inactive (not 
shown). 
The effects described in fig.1 and 2 were evaluated 
by double reciprocal plots of the increment in GTPase 
activity vs the concentrations of 3’-terminal fragments 
or aa-tRNA. Table 1 reported the values obtained for 
the concentrations required for half-maximum stimu- 
lation of the rate of the GTP hydrolysis. These values 
can be considered to represent the apparent dissocia- 
tion constant (Kd) of the aminoacylated 3’-terminal 
fragments or aa-tRNA from the EF-Tu . kirromycin 
complex. The required concentration for aa-tRNA is 
lower than for aminoacylddenosine by 2 orders of 
magnitude, while the difference is reduced to 1 order 
of magnitude only for the longer fragments. This 
already occurs with CA-Phe and CA-Val, indicating 
that the penultimate residue mostly contributes to 
the effect of the aminoacyl-oligonucleotides on the 
EF-Tu center for GTP hydrolysis. Ribosomes enhance 
Table 1 
Concentration of Phe-tRNAPhe, Val-tRNAVa’ and their 
3’-terminal fragments inducing half-maximum stimulation 





Phe-tRNAPhe 1.2 0.2 ’ 
CACCA-Phe 80 6 
CCA-Phe 100 6 
CA-Phe n.d. 10 
A-Phe 500 15 
Val-tRNAVal I .5 0.15 
CCA-Val 100 12 
CA-Val 100 17 
A-Val 1000 140 
_ 
The values represent the average of different experiments; 
n.d., not determined 
the sensitivity of the system from 6-l 5-times, without 
greatly changing the general picture. The difference in 
stimulation between A-Phe or A-Val and the longer 
fragments was retained also at infinite concentrations 
(not shown). 
The addition of cytosine 3’-monophosphate up to 
1 mM did not increase the weak effect of A-Phe or 
A-Val either in the absence or in the presence of ribo- 
somes (not shown). 
We also investigated whether puromycin, an anal- 
ogue of aminoacyladenosine, could stimulate the 
GTPase activity of EF-Tu in the presence of kirromy- 
tin. Neither in the presence, not in the absence of 
ribosomes were we able to observe any effect by using 
puromycin over 10 PM-S mM (not shown). 
4. Discussion 
The use of kirromycin to activate the EF-Tu center 
for GTP hydrolysis facilitates the study of the regula- 
tion of this activity by aa-tRNA, ribosomes and 
cations [S]. Moreover, it permits to quantify precisely 
the effects, since in the presence of kirromycin the 
rate-limiting step of the turnover of the GTPase activ- 
ity of EF-Tu is always GTP breakdown [6]. 
Our results show that 3’-terminal fragments of 
aa-tRNA are able to stimulate the catalytic activity of 
EF-Tu independently of the other domains of the 
aa-tRNA molecule. Though 2’(3’)a-L-aminoacyl- 
adenosine alone can stimulate the EF-Tu GTPase 
activity, the presence of the penultimate residue 
appears to be critical for a productive interaction with 
EF-Tu. The observation that addition of cytosine 
3’-monophosphate does not influence the effect of 
A-Phe or A-Val suggests that the cytidylic acid residue 
does not act directly on EF-Tu but affects the config- 
uration of the aminoacyl-adenosine moiety [ 141. The 
presence of other residues besides the penultimate 
residue appears to be less important. 
Ribosomes, which strongly stimulate the catalytic 
activity of EF-Tu . kirromycin, appear to favor the 
activity of the 3’-terminal fragments even more than 
that of aa-tRNA. This observation as well as the size 
of the observed effects point to a prominent role of 
the 3’-terminal end in the interaction between aa-tRNA 
and EF-Tu. That the intact molecule is still more 
active than the derived fragments may depend either 
on additional interactions between other domains of 
the tnolecule and EF-Tu, or on a more specific posi- 
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tioning of the 3’-terminal end due to the intact accep- 
tor stem. 
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Note added in proof 1101 
After submission of the manuscript we learnt, 
P. Bhuta and S. Chlzidek had just reported (FEBS 
Lett. 122, 1 13-l 16, 1980) that in their system in the 
presence of aurodox (=methylated kirromycin) the 
GTPase activity of EF-Tu was enhanced to the same 
extent by both A-Phe and CA-Phe, and even more 








We are greatly indebted to Drs G. Petrissant and 
G. Sander for stimulating discussions and criticism, 
and to Dr E. Perez for aiding us to purify the 3’-ter- 
minal fragments. This work was supported by NATO 
research grant 1706 and by the Commissariat 2 
I’Energie Atomique. 
Miller, D. L. and Weissbach, H. (1977) in: Molecular 
Mechanisms in Protein Biosynthesis (Weissbach, H. and 
Petska,S. cds) pp. 323-373, Academic Press, New York. 
Wolf, H., Chinali, G. and Parmqqiani, A. (1974) Proc. 
Natl. Acad. Sci. USA 71,4910-4914. 
Chinali,G., Wolf, H. and Parmcggiani, A. (1977) Eur. J. 
Biochem. 75,55-65. 
Wolf, H.,Chinali,G.and Parmeggiani, A. (1977) Eur. J. 
Biochcm. 75, 67-75. 
Parme@ani. A. and Sander, G. (1980) in: Topics in 
Antibioticchemistry (Sammes,P. ed) pp. 159-221, 
Wiley, New York, 
Bocchini, V., Parlato, G., De Vendittis, E., Sander, G. 
and Parmqgiani, A. (1980) Eur. J. Biochem. 113, 
53-60. 
Sander, G., Okonek, M., Ivell, R., Crcchet, J. B.. 
Bocchini, V. and Parmcggiani, A. (1979) FEBS Lett. 98, 
111-114. 
Sander, G., Ivell, R., Crechet, J. B. and Parmeggiani, A. 
(1980) Biochemistry 19, 865-870. 
Gillam, I., Millward, S., Blew, D., Von Tigerstrom, M., 
Winuncr, E. and Tener, G. M. (1967) Biochemistry 6, 
3043-3056. 
Holmes, W. M.. Hurd, R. E., Reid, B. R., Rimerman. 
R. A. and Iiatfield, G. W. (1975) Proc. Natl. Acad. Sci. 
USA 72.1068-1072. 
Monro, R. E.,Cernri, J. and Marcker, K. A. (1968) Proc. 
Natl. Acad. Sci. USA 61, 1042%1049. 
Donis-Keller,H.,Maxam,A. M. and Gilbert, W. (1977) 
Nucleic Acids Res. 4,2527--2538. 
Dormer, D., Villems, R., Liljas, A. and Kurland, C. G. 
(1978) Proc. Natl. Acad. Sci. USA 74, 1013-1015. 
Chcng, D.M., Danyluk, S. S., Dhingra, M. M., Ezra, 1:. S., 
MacCoss, M., Mitra,C. K. and Sarma, R. H. (1980) Bio- 
chemistry 19, 249 l-2497. 
Campuzano, S. and Modolell, J. (1980) Proc. Natl. 
Acad. Sci. USA 77,905-909. 
Jonik, J., Smrt, J., Hol$, A. and Rychlik, I. (1980) 
Eur. J. Biochem. 105, 315-320. 
260 
